RMTI - Rockwell Medical, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5195.39M
Enterprise Value 3146.19M
Trailing P/E N/A
Forward P/E 1-8.88
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)3.05
Price/Book (mrq)8.56
Enterprise Value/Revenue 32.28
Enterprise Value/EBITDA 6-4.33

Trading Information

Stock Price History

Beta (3Y Monthly) 1.43
52-Week Change 3-36.94%
S&P500 52-Week Change 36.34%
52 Week High 36.8800
52 Week Low 32.1900
50-Day Moving Average 33.4157
200-Day Moving Average 34.2561

Share Statistics

Avg Vol (3 month) 3423.26k
Avg Vol (10 day) 3373.43k
Shares Outstanding 557.57M
Float 52.77M
% Held by Insiders 119.62%
% Held by Institutions 138.12%
Shares Short (Jun 28, 2019) 46.67M
Short Ratio (Jun 28, 2019) 411.15
Short % of Float (Jun 28, 2019) 414.61%
Short % of Shares Outstanding (Jun 28, 2019) 410.37%
Shares Short (prior month May 31, 2019) 46.95M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -55.09%
Operating Margin (ttm)-53.91%

Management Effectiveness

Return on Assets (ttm)-43.15%
Return on Equity (ttm)-147.58%

Income Statement

Revenue (ttm)64M
Revenue Per Share (ttm)1.18
Quarterly Revenue Growth (yoy)4.10%
Gross Profit (ttm)-1.58M
EBITDA -33.79M
Net Income Avi to Common (ttm)-35.25M
Diluted EPS (ttm)-0.6500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.8M
Total Cash Per Share (mrq)0.48
Total Debt (mrq)3.02M
Total Debt/Equity (mrq)14.96
Current Ratio (mrq)2.56
Book Value Per Share (mrq)0.35

Cash Flow Statement

Operating Cash Flow (ttm)-21.24M
Levered Free Cash Flow (ttm)-11.09M